Bioreperia (private company)

See something wrong or missing? Let us know
Offices:Linköping
Registration number:559026-9360
Business model:B2B

Bioreperia is a Swedish company that developed a unique zebrafish technology platform for evaluating efficacy and toxicity for your substances.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 860k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Bioreperia

Name Criteria
Norway Age Labs AS
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Lithuania Biomatter Designs
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Switzerland Bionomous
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Cartana
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: < 1M USD
United Kingdom Novai
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Switzerland CyanoGuard
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Denmark Pipe|bio
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Valink Therapeutics
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Olombria
47%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Germany Atai Life Sciences
42%
  • Similar verticals: Biotech, Software Services
  • Similar business models: B2B
  • At least one other investor: found 3
Top